Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Working Capital to Net Assets Ratio
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a Working Capital to Net Assets ratio of 66.7% as of September 2025. Working capital of Rs1.69 Billion (current assets of Rs2.02 Billion minus current liabilities of Rs332.68 Million) is measured against net assets of Rs2.53 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Jagsonpal Pharmaceuticals Limited's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jagsonpal Pharmaceuticals Limited Working Capital to Net Assets (2006–2025)
This chart shows how Jagsonpal Pharmaceuticals Limited's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the ratio stands at 66.7%, reflecting working capital of Rs1.69 Billion against net assets of Rs2.53 Billion INR. Check Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Jagsonpal Pharmaceuticals Limited (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jagsonpal Pharmaceuticals Limited from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Jagsonpal Pharmaceuticals Limited market capitalisation.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 56.4% | Rs1.35 Billion | Rs2.40 Billion | Rs1.61 Billion | Rs259.04 Million | ▼ -39.7 pp |
| 2024 | 96.1% | Rs1.80 Billion | Rs1.87 Billion | Rs1.99 Billion | Rs191.28 Million | ▲ +9.9 pp |
| 2023 | 86.2% | Rs1.37 Billion | Rs1.59 Billion | Rs1.65 Billion | Rs275.72 Million | ▲ +23.5 pp |
| 2022 | 62.7% | Rs821.09 Million | Rs1.31 Billion | Rs1.09 Billion | Rs269.72 Million | ▼ -2.9 pp |
| 2021 | 65.7% | Rs800.80 Million | Rs1.22 Billion | Rs1.20 Billion | Rs403.97 Million | ▲ +9.8 pp |
| 2020 | 55.9% | Rs620.81 Million | Rs1.11 Billion | Rs949.10 Million | Rs328.29 Million | ▼ -10.5 pp |
| 2019 | 66.4% | Rs693.66 Million | Rs1.04 Billion | Rs975.58 Million | Rs281.92 Million | ▼ -0.9 pp |
| 2018 | 67.3% | Rs660.30 Million | Rs980.47 Million | Rs946.13 Million | Rs285.83 Million | ▼ -6.1 pp |
| 2017 | 73.4% | Rs806.78 Million | Rs1.10 Billion | Rs1.10 Billion | Rs294.36 Million | ▲ +29.0 pp |
| 2016 | 44.4% | Rs436.50 Million | Rs983.64 Million | Rs1.01 Billion | Rs573.09 Million | ▲ +1.8 pp |
| 2015 | 42.5% | Rs406.01 Million | Rs954.26 Million | Rs957.93 Million | Rs551.92 Million | ▲ +4.3 pp |
| 2014 | 38.3% | Rs377.30 Million | Rs985.89 Million | Rs913.14 Million | Rs535.85 Million | ▲ +1.3 pp |
| 2013 | 37.0% | Rs364.13 Million | Rs983.71 Million | Rs865.43 Million | Rs501.30 Million | ▼ -1.1 pp |
| 2012 | 38.1% | Rs375.53 Million | Rs984.69 Million | Rs909.30 Million | Rs533.77 Million | ▼ -34.2 pp |
| 2011 | 72.3% | Rs671.92 Million | Rs929.14 Million | Rs790.35 Million | Rs118.43 Million | ▲ +6.4 pp |
| 2010 | 66.0% | Rs577.56 Million | Rs875.70 Million | Rs700.50 Million | Rs122.94 Million | ▼ -5.4 pp |
| 2009 | 71.4% | Rs572.10 Million | Rs801.68 Million | Rs692.90 Million | Rs120.81 Million | ▼ -23.6 pp |
| 2008 | 95.0% | Rs712.79 Million | Rs750.34 Million | Rs837.26 Million | Rs124.47 Million | ▲ +32.7 pp |
| 2007 | 62.3% | Rs451.69 Million | Rs724.98 Million | Rs1.04 Billion | Rs585.87 Million | ▲ +0.7 pp |
| 2006 | 61.6% | Rs432.67 Million | Rs702.35 Million | Rs1.05 Billion | Rs615.92 Million | — |